Rankings
▼
Calendar
KURA Q3 2016 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena
KURA
Kura Oncology, Inc.
$802M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.37
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$584,000
Balance Sheet
Total Assets
$76M
Total Liabilities
$13M
Stockholders' Equity
$64M
Cash & Equivalents
$7M
← FY 2016
All Quarters
Q4 2016 →
